Long-term outcomes of aplastic anemia with cytogenetic abnormalities at diagnosis.
Jianping LiXu LiuXin ZhaoWenrui YangLi ZhangLiping JingKang ZhouLei YeYuan LiYang LiGuangxin PengLin SongHuihui FanXiangrong HuXiaoxia LiFengkui ZhangPublished in: European journal of haematology (2022)
For AA patients with chromosome abnormalities but ineligible for HSCT, IST is effective and appropriate as first-line treatment. This article is protected by copyright. All rights reserved.